Behavioral Health Psychotropics

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC53-14

DiraChart Clinical Reference
Protected section 14 of 15
← Document menu
Nursing Home · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 14 of 15PreviousNext

Daily-note bank — change-of-condition / at-risk days

Scenario

Model daily note (edit to the shift)

Failed GDR with rationale

Increased aggression and return of paranoid delusions during a GDR trial — provider notified with data, GDR clinically contraindicated and rationale recorded, non-pharm intensified, monitoring continued, Section E/care plan updated.

Behavior change, medical cause

Acute agitation/confusion from baseline with fever and reduced intake — screened for a medical trigger, provider notified, workup ordered, non-pharm measures in place, unnecessary psychotropic avoided; reassess; SCSA evaluated.

Antipsychotic adverse effect

New pill-rolling tremor and rigidity (EPS) on the antipsychotic — held per protocol, provider notified, dose re-evaluated; adverse effect and fall risk documented; care plan revised.

Linked disease-specific scenarios

Dementia-specific BPSD approaches and antipsychotic caution route to the Dementia overlay; acute psychiatric emergencies route to the Psychiatric reference; restraint use routes to the Restraints reference; pain-driven behavior routes to the Pain reference.

Section NavigationPart 14 of 15PreviousNext